Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP8128)
Name
Rhein
Synonyms
Rhein; 478-43-3; Monorhein; Rheic acid; Rhubarb Yellow; Cassic acid; 4,5-Dihydroxyanthraquinone-2-carboxylic acid; 4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid; Chrysazin-3-carboxylic acid; 1,8-Dihydroxy-3-carboxyanthraquinone; Rheinic acid; NSC 38629; 1,8-Dihydroxyanthraquinone-3-carboxylic acid; MFCD00009618; 2-Anthracenecarboxylic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-; UNII-YM64C2P6UX; 4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid; Rhein (1,8-dihydroxy-3-carboxyl anthraquinone); 9,10-Dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid; YM64C2P6UX; MLS000069639; CHEBI:8825; 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-; 4,5-Dihydroxy-2-anthraquinonecarboxylic acid; 4,5-DiOH-anthraquinone-2-COOH; SMR000058210; ST057726; dipropionyl rhein; 1,8-DIHYDROXY-3-CARBOXYL ANTHRAQUINONE; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic acid; Rhein(Monorhein); CCRIS 5129; C15H8O6; EINECS 207-521-4; BRN 2222155; Rhein - Monorhein; RHN; Rhein,(S); Rhein; Rhubarb Yellow; Rhein, technical grade; 4ie7; ACMC-209kan; regid855879; Rhein-[13C6]; DSSTox_CID_6000; Rhein, analytical standard; 1,8-dihydroxy-3-carboxyl-9,10-anthraquinone; DSSTox_RID_77984; DSSTox_GSID_26000; SCHEMBL25253; US9238626, Rhein; 4-10-00-04088 (Beilstein Handbook Reference); cid_10168; MLS006011744; CHEMBL418068; MEGxp0_001866; 4,5-dihydroxy-9,10-dioxo-anthracene-2-carboxylic acid; DTXSID4026000; ACon1_000217; BDBM32021; ACT03257; BCP28202; HY-N0105; NSC38629; ZINC4098704; Tox21_201098; ANW-30573; BBL009695; CR0016; LMPK13040015; NSC-38629; s2400; SBB001152; STL141046; AKOS005259272; AC-7978; ACN-035339; CS-5239; DB13174; MCULE-1248137705; NCGC00018199-01; NCGC00018199-02; NCGC00018199-03; NCGC00018199-04; NCGC00018199-05; NCGC00018199-06; NCGC00018199-07; NCGC00023342-03; NCGC00023342-04; NCGC00258650-01; AK-88490; AM807834; AS-11635; CAS-478-43-3; SY051290; AB0010467; DB-014981; D3986; FT-0645050; FT-0674401; N1810; 4, 5-Dihydroxyanthraquinone-2-carboxylic acid; 2-Anthraquinonecarboxylic acid, 4,5-dihydroxy-; 78R433; C10401; X-4365; Q720356; Q-100512; 4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid; BRD-K27335680-001-01-9; 2-Anthroic acid,10-dihydro-4,5-dihydroxy-9,10-dioxo-; 4,5-dihydroxy-9,10-diketo-anthracene-2-carboxylic acid; 2-Anthracenecarboxylic acid,10-dihydro-4,5-dihydroxy-9,10-dioxo-; 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo- (8CI); 4,5-bis(oxidanyl)-9,10-bis(oxidanylidene)anthracene-2-carboxylic acid; 4,5-Dihydroxy-9,10-dioxo-9,10-dihydro-2-anthracenecarboxylic acid #; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracene carboxylic acid; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, 9CI
    Click to Show/Hide
Species Origin Rheum palmatum ...     Click to Show/Hide
Rheum palmatum
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Caryophyllales
Family: Polygonaceae
Genus: Rheum
Species: Rheum palmatum
Disease Colitis [ICD-11: 1A40] Investigative [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C15H8O6
PubChem CID
10168
Canonical SMILES
C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)C(=O)O
InChI
1S/C15H8O6/c16-9-3-1-2-7-11(9)14(19)12-8(13(7)18)4-6(15(20)21)5-10(12)17/h1-5,16-17H,(H,20,21)
InChIKey
FCDLCPWAQCPTKC-UHFFFAOYSA-N
CAS Number
CAS CAS 478-43-3
ChEBI ID
CHEBI:8825
Herb ID
HBIN042199
SymMap ID
SMIT00146
TCMSP ID
MOL002268
TTD Drug ID
D0M2TY
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Calphostin c      Breast cancer     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression XIAP  Molecule Info 
Pathway MAP
                    In-vitro Model HCT 116 CVCL_0291 Colon carcinoma Homo sapiens
RKO CVCL_0504 Colon carcinoma Homo sapiens
                    Experimental
                    Result(s)
Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
Target and Pathway
Target(s) Heat shock protein 90 alpha (HSP90A)  Molecule Info  [3]
KEGG Pathway Protein processing in endoplasmic reticulum Click to Show/Hide
2 PI3K-Akt signaling pathway
3 Antigen processing and presentation
4 NOD-like receptor signaling pathway
5 Progesterone-mediated oocyte maturation
6 Estrogen signaling pathway
7 Pathways in cancer
8 Prostate cancer
NetPath Pathway IL2 Signaling Pathway Click to Show/Hide
2 TCR Signaling Pathway
Pathway Interaction Database Signaling events mediated by HDAC Class II Click to Show/Hide
2 Validated targets of C-MYC transcriptional activation
3 Integrin-linked kinase signaling
4 LKB1 signaling events
5 Regulation of Telomerase
6 Glucocorticoid receptor regulatory network
7 Class I PI3K signaling events
8 IL2 signaling events mediated by PI3K
9 Regulation of Androgen receptor activity
10 Integrins in angiogenesis
11 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha
12 ErbB receptor signaling network
13 VEGFR1 specific signals
14 Signaling events mediated by VEGFR1 and VEGFR2
15 Class I PI3K signaling events mediated by Akt
Reactome Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Click to Show/Hide
2 Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
3 Regulation of actin dynamics for phagocytic cup formation
4 eNOS activation
5 Regulation of PLK1 Activity at G2/M Transition
6 Attenuation phase
7 HSF1-dependent transactivation
8 Loss of Nlp from mitotic centrosomes
9 Recruitment of mitotic centrosome proteins and complexes
10 Loss of proteins required for interphase microtubule organization?from the centrosome
11 EPHA-mediated growth cone collapse
12 VEGFA-VEGFR2 Pathway
13 VEGFR2 mediated vascular permeability
14 Anchoring of the basal body to the plasma membrane
15 Constitutive Signaling by EGFRvIII
WikiPathways NRF2 pathway Click to Show/Hide
2 Nuclear Receptors Meta-Pathway
3 Aryl Hydrocarbon Receptor Pathway
4 Binding and Uptake of Ligands by Scavenger Receptors
5 Signaling by ERBB2
6 Fcgamma receptor (FCGR) dependent phagocytosis
7 Influenza Life Cycle
8 EBV LMP1 signaling
9 Aryl Hydrocarbon Receptor
10 Corticotropin-releasing hormone
11 TNF alpha Signaling Pathway
12 Arylhydrocarbon receptor (AhR) signaling pathway
13 Signaling by EGFR
14 Semaphorin interactions
15 Mitotic G2-G2/M phases
16 Metabolism of nitric oxide
17 NOD pathway
References
Reference 1 Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis. Theranostics. 2020 Aug 29;10(23):10665-10679.
Reference 2 Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res. 2003 Aug 15;63(16):5118-25.
Reference 3 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China